These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9657096)

  • 101. Hepatocellular function and nutrient blood flow in experimental peritonitis.
    Garrison RN; Ratcliffe DJ; Fry DE
    Surgery; 1982 Oct; 92(4):713-9. PubMed ID: 7123492
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Hepatic function related to the ICG test--evaluation by using principle component analysis and multiple regression analysis].
    Shirata T; Wada Y; Watanabe H; Miyazawa K; Shinzawa H
    Rinsho Byori; 1985 Mar; 33(3):330-4. PubMed ID: 4010005
    [No Abstract]   [Full Text] [Related]  

  • 103. Hepatic plasma flow: accuracy of estimation from bolus injections of indocyanine green.
    Burczynski FJ; Pushka KL; Sitar DS; Greenway CV
    Am J Physiol; 1987 May; 252(5 Pt 2):H953-62. PubMed ID: 3578545
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Clinical aspects of indocyanine green pharmacokinetics following portal vein administration.
    Nishi S; Shindo M; Abe J; Asada A
    Br J Clin Pharmacol; 1998 Jan; 45(1):41-7. PubMed ID: 9489593
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Liver function assessment by drug metabolism.
    Barstow L; Small RE
    Pharmacotherapy; 1990; 10(4):280-8. PubMed ID: 2388874
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Assessment of hepatic blood flow using continuous infusion of high clearance drugs.
    Schoemaker RC; Burggraaf J; Cohen AF
    Br J Clin Pharmacol; 1998 May; 45(5):463-9. PubMed ID: 9643619
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Prediction by mathematical simulation of different pathophysiological effects on D-sorbitol bioavailability.
    Torchio M; Battista S; Bar F; Molino G
    Comput Biol Med; 1998 Mar; 28(2):91-104. PubMed ID: 9684087
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures.
    Keiding S; Ott P; Bass L
    J Hepatol; 1993 Nov; 19(3):327-44. PubMed ID: 8151094
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Indocyanine green plasma disappearance rate. Marker of partial hepato-splanchnic ischemia].
    Thümer O; Hüttemann E; Sakka SG
    Anaesthesist; 2007 Apr; 56(4):339-44. PubMed ID: 17279343
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green.
    Uusaro A; Ruokonen E; Takala J
    Cardiovasc Res; 1995 Jul; 30(1):106-12. PubMed ID: 7553712
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.
    Burggraaf J; Schoemaker RC; Lentjes EG; Cohen AF
    Eur J Pharm Sci; 2000 Dec; 12(2):133-9. PubMed ID: 11102741
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The effect of PGE2 on hepatic blood flow and bile indocyanin green in the rat.
    Bruck R; Krepel Z; Melzer E; Bar-Meir S
    Prostaglandins; 1989 May; 37(5):531-8. PubMed ID: 2740524
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Hepatic ICG removal in the pig depends on plasma protein and hematocrit: evidence of sinusoidal binding disequilibrium and unstirred water layer effects.
    Ott P; Bass L; Keiding S
    Hepatology; 1997 Sep; 26(3):679-90. PubMed ID: 9303499
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance.
    Haimerl M; Jung EM; Beyer LP; Pregler B; Dollinger M; Sieroń D; Niessen C; Stroszczynski C; Wiggermann P
    Clin Hemorheol Microcirc; 2015; 61(2):195-204. PubMed ID: 26410870
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.
    Grainger SL; Keeling PW; Brown IM; Marigold JH; Thompson RP
    Clin Sci (Lond); 1983 Feb; 64(2):207-12. PubMed ID: 6822056
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Hepatic blood volume is decreased in patients with cirrhosis and does not decrease further after a meal like in healthy persons.
    Sørensen M
    Scand J Gastroenterol; 2021 Oct; 56(10):1205-1209. PubMed ID: 34330201
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Comparison of bolus and infusion methods for estimating hepatic blood flow in patients with liver disease using indocyanine green.
    Clements D; West R; Elias E
    J Hepatol; 1987 Dec; 5(3):282-7. PubMed ID: 3429835
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Indocyanine green plasma clearance as a measure of changes in hepatic blood flow.
    Kanstrup IL; Winkler K
    Clin Physiol; 1987 Feb; 7(1):51-4. PubMed ID: 3816112
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Intrinsic hepatic clearance of indocyanine green in the pig: dependence on plasma protein concentration.
    Ott P; Keiding S; Bass L
    Eur J Clin Invest; 1992 May; 22(5):347-57. PubMed ID: 1592087
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Postural changes in hepatic plasma flow in patients with chronic active liver disease. Use of bromosulphthalein loading test without hepatic venous catheterization.
    Buzzelli G; Chiarantini E; Orioli S; Arcangeli A; Matassi L; Simondi P; Gentilini P
    Quad Sclavo Diagn; 1985 Mar; 21(1):47-55. PubMed ID: 4059511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.